Valereum PLC - Director/PDMR Shareholding
Announcement provided by
Valereum Plc · VLRM03/09/2026 18:11

Date: 3 September 2026
FOR IMMEDIATE RELEASE (Aquis Stock Exchange: VLRM)
Valereum Plc
("Valereum", "VLRM" or the "Company")
Directors' Dealing
Valereum Plc (AQSE: VLRM | OTCQB: VLRMF), a company aiming to become the global market leader in the tokenised digital markets sector, has been notified by its Group CEO, Gary Cottle that he has purchased 337,635 ordinary shares in the Company on the market on 28 August 2026. Following these transactions, he holds a total of 21,289,248 ordinary shares in the Company, representing approximately 3.92% of the issued share capital of the Company at the time of purchase.
Following the further issue of shares by the Company on 2 September 2026, as announced on 27 August 2026, his holding represents approximately 3.56% of the Company's issued share capital as at the date of this announcement.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation), which is part of
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||||||||
|
a) |
Name: |
Gary Cottle |
||||||||||||||
|
2. |
Reason for the notification |
|||||||||||||||
|
a) |
Position/status: |
Chief Executive Director |
||||||||||||||
|
b) |
Initial notification/Amendment: |
Initial Notification |
||||||||||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||||
|
a) |
Name: |
Valereum Plc |
||||||||||||||
|
b) |
LEI: |
213800EJ8BFEQQ9POX79 |
||||||||||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||||
|
a) |
Description of the financial instrument, type of instrument: Identification code: |
Ordinary Shares of GI000A2P2W41
|
||||||||||||||
|
b) |
Nature of the transaction: |
Purchase of ordinary shares |
||||||||||||||
|
c) |
Price(s) and volume(s): |
|
||||||||||||||
|
d) |
Aggregated information: Aggregated volume: Price: |
337,635 ordinary shares |
||||||||||||||
|
e) |
Date of the transaction: |
28 August 2026 |
||||||||||||||
|
f) |
Place of the transaction: |
Aquis Stock Exchange |
||||||||||||||
For further information, please contact:
|
Valereum Plc Karl Moss |
Tel: +44 7938 767319 |
|
Fortified Securities Guy Wheatley |
Tel: +44 203 4117773 |
|
Aquis Corporate Adviser Guild Financial Advisory Limited Ross Andrews |
E: ross.andrews@guildfin.co.uk |
The Directors of the Company accept responsibility for the contents of this announcement.
Please visit the Company's website at www.vlrm.com
For more information, and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: Investor Hub.
IMPORTANT NOTICES
The Company holds cryptocurrencies or crypto assets in its treasury. Whilst the Board of Directors of the Company considers holding cryptocurrencies to be in the best interests of the Company, the Board remains aware that the financial regulator in the
The Company is neither authorised nor regulated by the FCA, and the purchase of certain cryptocurrencies are generally unregulated in the
Cryptocurrencies may present special risks to the Company's financial position. These risks include (but are not limited to): (i) the value of cryptocurrencies can be highly volatile, with value dropping as quickly as it can rise. Investors in cryptocurrencies must be prepared to lose all money invested in cryptocurrencies; (ii) the cryptocurrencies market is largely unregulated. There is a risk of losing money due to risks such as cyber-attacks, financial crime and counterparty failure; (iii) the Company may not be able to sell its cryptocurrencies at will. The ability to sell cryptocurrencies depends on various factors, including the supply and demand in the market at the relevant time. Operational failings such as technology outages, cyber-attacks and commingling of funds could cause unwanted delay; and (iv) crypto assets are characterised in some quarters by high degrees of fraud, money laundering and financial crime. Prospective investors in the Company are encouraged to do their own research before investing.
The Company also holds digital tokens as part of its strategy to become the global market leader in the rapidly developing tokenised digital markets sector. Whilst the Board of Directors of the Company considers holding tokens to be in the best interests of the Company, it is important to note that an investment in the Company is not a direct or indirect ownership interest, security, or claim in respect of any underlying asset or reserve to which a token may relate. The valuation of tokens, particularly those linked to mining reserves or other physical assets, is inherently uncertain and may depend on independent third-party verification. Further risks include the liquidity of the tokenised markets, reliance on the security and continued operation of underlying blockchain or smart contract infrastructure, counterparty and custody risk in respect of third party platforms, the risk of misrepresentation or fraud regarding underlying reserves, and evolving regulatory, tax, and accounting treatment. It should not be assumed that tokens carry rights or protections to traditional securities or regulated investment products and investors are encouraged to conduct their own due diligence on the Company's exposure to tokenised assets before making any investment decision.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.